Investigating the impact of posaconazole prophylaxis on systematic fungal screening using galactomannan antigen, Aspergillus fumigatus qPCR, and Mucorales qPCR

Affiliations

¹ Parasitology Mycology Department, University Hospital, Besançon, France. Electronic address: apbellanger@chu-besancon.fr.
² Parasitology Mycology Department, University Hospital, Besançon, France.
³ Pharmacy Department, University Hospital, Besançon, France.
⁴ Hematology Department, University Hospital, Besançon, France.
⁵ Pharmacology Department, University Hospital, Besançon, France.
⁶ Infection Control Department, University Hospital, Besançon, France.

Anne-Pauline Bellanger et al. J Mycol Med. 2021 Jun.

. 2021 Jun;31(2):101117.

doi: 10.1016/j.mycmed.2021.101117. Epub 2021 Jan 28.

¹ Parasitology Mycology Department, University Hospital, Besançon, France. Electronic address: apbellanger@chu-besancon.fr.
² Parasitology Mycology Department, University Hospital, Besançon, France.
³ Pharmacy Department, University Hospital, Besançon, France.
⁴ Hematology Department, University Hospital, Besançon, France.
⁵ Pharmacology Department, University Hospital, Besançon, France.
⁶ Infection Control Department, University Hospital, Besançon, France.

No abstract available

Keywords: Antifungal prophylaxis; Aspergillus fumigatus qPCR; Posaconazole; Prophylaxie antifongique; QPCR Aspergillus fumigatus.

Publication types